Neuromodulation device
The present invention provides devices and methods that can prevent or ameliorate bronchoconstriction by stimulating neural activity, in contrast to those techniques based on denervation, ablation or blocking of neural activity. Methods and devices according to the invention may act responsively or on demand, can preserve neuronal structure and function and will be associated with minimal collateral side-effects. In particular, the invention provides devices and methods in which a signal is delivered to the vagus nerve, for example the cervical vagus nerve or the pulmonary branch of the vagus nerve, in order to stimulate neural activity in the vagal nerve.
1. A method of treating bronchoconstriction in a patient, the method comprising:
applying an electrical signal by a neuromodulation device partially implanted in the patient and positioned in signaling contact with a pulmonary branch of a vagal nerve of the patient, wherein the neuromodulation device comprises one or more electrodes that apply the electrical signal to afferent A fibers of the vagal nerve of said patient to selectively stimulate neural activity in the afferent A fibers of the vagal nerve in said patient, while not stimulating efferent fibers or afferent Aδ fibers, wherein the electrical signal—has a frequency in the range of 50-150 Hz, and wherein the electrical signal has a pulse duration of 0.005-0.1 ms, such that the electrical signal to the vagal nerve produces an improvement in a physiological parameter indicative of treating bronchoconstriction in the patient,
providing a detector for detecting the physiological parameter; and
measuring the physiological parameter, wherein the physiological parameter is airway smooth muscle (ASM) tone, blood oxygen saturation, blood carbon dioxide concentration, tidal mid-expiratory flow, respiratory rate, total lung capacity, or forced expiration volume;
wherein the improvement in the physiological parameter is a decrease in airway smooth muscle tone, an increase in blood oxygen saturation, a decrease in blood carbon dioxide concentration, an increase in tidal mid-expiratory flow, a decrease in respiratory rate, an increase in total lung capacity, or an increase in forced expiration volume, from an initial measurement.
2. A method according to claim 1 , wherein the electrical signal has a pulse duration of 0.01-0.06 ms.
3. A method according to claim 1 , wherein the electrical signal has a current of 1-8000 μA.
4. A method according to claim 1 , wherein the electrical signal is applied only when the measured physiological parameter meets or exceeds a predefined threshold value.
5. A method according to claim 1 , wherein the method of treating bronchoconstriction is a method of treating asthma or COPD.
6. The method according to claim 1 , wherein applying the electrical signal further comprises an intermittent signaling wherein the electrical signal is applied for a first time period, stopped for a second time period, reapplied for a third time period, and stopped for a fourth time period.
7. The method according to claim 6 , wherein the first time period, second time period, third time period, and fourth time period run sequentially and consecutively.
8. The method of claim 1 , wherein the signal is applied for one or more time periods between 5 seconds and 24 hours.
9. A method according to claim 1 , wherein the electrical signal has a pulse duration of 0.01-0.05 ms.
10. A method according to claim 1 , wherein the electrical signal has a pulse duration of 0.01-0.04 ms.
11. A method according to claim 1 , wherein the electrical signal has a pulse duration of 0.01-0.03 ms.
12. A method of treating a bronchoconstriction in a patient, wherein the method comprises:
i. applying a signal to a pulmonary branch of a vagal nerve of said patient to selectively stimulate neural activity in afferent A fibers, while not stimulating efferent fibers or afferent Aδ fibers, of the vagal nerve, wherein the signal is applied by a neuromodulation device partially implanted in the patient and positioned in signaling contact with the vagal nerve, the neuromodulation device comprising one or more transducers configured to apply the signal, wherein the signal has a frequency of 50-150 Hz, and wherein the signal has a pulse duration of 0.05-0.1 ms, such that the signal to the vagal nerve produces an improvement in a physiological parameter indicative of treating bronchoconstriction in the patient;
ii. providing a detector for detecting the physiological parameter;
iii. administering a bronchodilator to the patient; and
iv. measuring the physiological parameter, wherein the physiological parameter is airway smooth muscle (ASM) tone, blood oxygen saturation, blood carbon dioxide concentration, tidal mid-expiratory flow, respiratory rate, total lung capacity, or forced expiration volume;
wherein the improvement in the physiological parameter is a decrease in airway smooth muscle tone, an increase in blood oxygen saturation, a decrease in blood carbon dioxide concentration, an increase in tidal mid-expiratory flow, a decrease in respiratory rate, an increase in total lung capacity, or an increase in forced expiration volume, from an initial measurement.
13. The method of claim 12 , wherein the signal is applied for one or more time periods.
14. The method of claim 13 , wherein applying the signal further comprises an intermittent signaling wherein the signal is applied for a first time period, stopped for a second time period, reapplied for a third time period, and stopped for a fourth time period.
15. A system for stimulating neural activity in a vagal nerve of a patient to treat bronchoconstriction in the patient, the system comprising:
at least one transducer, configured to be in signaling contact with a pulmonary branch of a vagal nerve, the at least one transducer configured to be at least partially implanted in the patient; and
a voltage or current source configured to generate a signal to be selectively applied to afferent A fibers of the vagal nerve of the patient, while not stimulating efferent fibers or afferent Aδ fibers, via the at least one transducer, wherein the signal has a frequency of 50-150 Hz, and wherein the signal has a pulse duration of between 0.005 and 0.1 ms, such that the signal to the vagal nerve produces an improvement in a physiological parameter indicative of treating bronchoconstriction in the patient, wherein the system further comprises a detector for detecting the physiological parameter, and
wherein the improvement in the physiological parameter is a decrease in airway smooth muscle tone, an increase in blood oxygen saturation, a decrease in blood carbon dioxide concentration, an increase in tidal mid-expiratory flow, a decrease in respiratory rate, an increase in total lung capacity, or an increase in forced expiration volume, from an initial measurement.